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A 20-community randomized controlled trial, the Alcohol
Action in Rural Communities (AARC) project, provided
the opportunity to examine the cost-effectiveness of
screening and brief intervention (SBI) delivered simulta-
neously in general practice (GP), pharmacy, and emer-
gency department (ED) settings and the community level
impact of the SBI on problem drinking. For the GP- and
pharmacy-delivered SBI, decision models and scenario
analysis assessed outcomes and costs in the 10 experimen-
tal communities of the trial. For the ED-delivered SBI, a
randomized controlled trial design was used to examine
the cost-effectiveness of mailed personalized feedback. For
both the GP- and pharmacy-delivered SBI, the most cost-
effective outcome was to increase screening alone: GPs
and pharmacies screening all patients achieved an incre-
mental cost-effectiveness ratio (ICER) of AUD $197 and
AUD $29, respectively, per risky drinker who reduced
drinking. The ED-based SBI resulted in a reduction of
2.6 fewer drinks per week at an average cost of $5.55 per
patient and an ICER of $2.13 per one standard drink
reduction in average weekly consumption. In addition to
cost-effectiveness, the AARC community approach pro-
vided the opportunity to analyze the effect of SBI on com-
munity level outcomes. Currently, 19% of risky drinkers in
a community visit a GP and reduce their drinking, which
would increase to 36% if all patients got SBI. Similarly,
23% of risky drinkers in a community visit a pharmacy
and reduce their drinking, which would increase to 34% if
they all got SBI. Although our results confirm SBI is cost-
effective, the impact at the community level is unclear: if
all GPs and pharmacists delivered SBI to all their risky
drinking patients, only 34-36% would reduce their drink-
ing. A trial that assessed the impact of SBI delivered in
multiple settings simultaneously on community level indi-
cators of alcohol harm would move the field toward
demonstrating the cost benefit, as well as cost-effectiveness,
of SBI.
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